Partners Janet Spreen and Asim Grabowski-Shaikh lead a team representing Actuate Therapeutics in an anticipated IPO that will help elevate a quiet month for new listings, per an article in Law360 titled “8 Firms to Lead 4 IPOs Totaling $806M as Action Heats Up.” The cancer-focused technology company filed plans to offer 5.6 million shares priced between $8 and $10, raising $50 million at midpoint.